Share and owner information

Shares in Alligator Bioscience AB are listed on the NASDAQ OMX Nordic Exchange (Stockholm) under the designation ATORX. Companies on NASDAQ OMX Nordic Exchange are divided into three segments: Large Cap, Mid Cap and Small Cap. Nordic companies with a market value over one billion euro are presented within the Nordic Large Cap segment. Companies with a market value between 150 million and 1 billion euro are contained within the Mid Cap segment, while companies with a market value below 150 million euro are contained in the Small Cap segment. The segments are revised every six months, on 1 January and 1 July, based on the weighted average price for May and November. Alligator Bioscience is currently listed in the Mid Cap segment.

The number of ordinary shares is 71,388,615. Each share entitles the holder to one vote at the Annual General Meeting.

Here you find the latest stock price information regarding the Alligator Bioscience share

Insider trading (Finansinspektionen/The Swedish Securities and Exchange Commission)

Shareholders

The 20 largest shareholders as of April 30, 2018.
Shareholders
No Of Shares
Percentage Shares
Banque Internationale à Luxembourg SA 13.660.551 19.1
Johnson & Johnson Innovation 5.762.523 8.1
Sunstone Life Science Ventures Fund II K/S 5.758.485 8.1
Lars Spånberg 3.213.858 4.5
Goldman Sachs & Co LLC 2.640.000 3.7
Norron 2.218.237 3.1
Öresund, Investment AB 1.730.910 2.4
Öhmans fonder 1.519.987 2.1
Catella fonder 1.512.251 2.1
Gladiator 1.500.000 2.1
Stena AB 1.401.339 2.0
Mikael Lönn 1.288.734 1.8
Johan Rockberg 1.263.982 1.8
Fjärde AP-fonden 1.241.148 1.7
Carl Borrebaeck 1.200.833 1.7
Unionen 1.140.886 1.6
JP Morgan fonder 1.071.122 1.5
Clearstream Banking S.A. 1.051.766 1.5
Ålandsbanken 978.064 1.4
Försäkringsbolaget Avanza pension 879.883 1.2
Other shareholders 20.354.056 28.5
Total shares 71.388.615 100.0